Among men with unfavorable-risk, nonmetastatic prostate cancer, the use of androgen deprivation therapy (ADT) was not associated with an increase in cardiovascular mortality as some previous studies had suggested, according to results of a...
Among men with unfavorable-risk, nonmetastatic prostate cancer, the use of androgen deprivation therapy (ADT) was not associated with an increase in cardiovascular mortality as some previous studies had suggested, according to results of a...
Among men with unfavorable-risk,...